Attorney at Work

JANUARY 9, 2024

Teddy Snyder | Communicating ignorance does not make you sound smart or powerful. The post Innumeracy Strikes Again — and Again appeared first on Attorney at Work.

196

196

Hanzo Blog

JANUARY 9, 2024

As we step into 2024, the legal industry continues to be reshaped by technological advancements. This year promises to bring new developments that could revolutionize how legal professionals work and interact with clients.

Technology 114

Technology 114

IP Watchdog

JANUARY 9, 2024

The U.S. Patent and Trademark Office (USPTO) published guidelines for examiners today on the topic of enablement in light of the Supreme Court’s May 2023 decision in Amgen v. Sanofi. The Office’s view seems to largely mesh with what our guest authors concluded earlier today—Amgen isn’t getting rid of In re Wands and—at the USPTO at least—the decision has seemingly maintained the status quo.

114

114

Lawmatics

JANUARY 9, 2024

Advances in legal software are rapidly transforming the future of legal technologies. Solutions leveraging automation, AI, and cloud platforms are reshaping law practices of all sizes. But for small and mid-size firms, the most transformative innovations are tools that directly strengthen client relationships, service quality, and firm capabilities.

Technology 130

Technology 130

Advertiser: Trellis

Trellis AI leverages the largest repository of state trial court data to help litigators evaluate cases, automate brief drafting, suggest winning strategies, and more. Key components: Draft Arguments — Uses similar/successful motions in the Trellis database to generate arguments/citations for your motions seeking dismissal, summary judgment, etc. Case Assessment — Predict the likely outcomes of a case at any stage to help you decide to accept it, guide motion practice, make settlement offers, an

Litigation

IP Watchdog

JANUARY 9, 2024

Last term, the U.S. Supreme Court did something strange: the Court unanimously affirmed a circuit decision, which had unanimously affirmed a trial court decision. Little about the law seemed ripe for dispute or change, nevertheless, in Amgen v. Sanofi the Supreme Court spoke. Seven months later, innovators and patent practitioners are still scratching their heads.

Litigation 111

Litigation 111

IP Watchdog

JANUARY 9, 2024

The U.S. Court of Appeals for the Federal Circuit (CAFC) today affirmed two decisions of the Patent Trial and Appeal Board (PTAB) that invalidated some claims and upheld others of a patent owned by Personal Genomics Taiwan, Inc. Based on the PTAB’s claim construction, which the CAFC agreed with, the decision held that Pacific Biosciences had failed to prove the prior art taught the limitation of the preamble phrase of claim 1 in one inter partes review, (IPR) but did prove a different prior art

Construction 64

Construction Litigation 64